BFACT specializes in creating new technology to treat cancer and tumors, focusing on refractory and AYA generation tumors with unmet medical needs. Their drugs aim to provide proper medical treatment for rare diseases and tumors, ensuring patients have access to effective therapies. BFACT's expertise lies in the development of antibody drugs, which have the potential to address the specific challenges associated with these types of cancers.